Testimony, Comments, & Letters

Comments on updated HIV & hepatitis strategic plans

As a policy and advocacy organization we work to ensure there are the proper policies, programs, and funding to implement the Strategic Plans. We also refer to them in our work with the Congress, media, and the public to help educate them on the strategic plans and national goals included in each of the plans. We use them to measure our progress in meeting the goals. We not only use them to advocate before the Congress but also within government agencies and leadership to hold them accountable to ensure the goals are reached and that proper policies and programs are in place with sufficient funding.

read more

Substandard & discriminatory HIV medication plan design and coverage by Medica in Minnesota

These benefit designs, which discourage enrollment by Minnesotans living with HIV, are plainly discriminatory.  We urge the Department of Commerce’s Insurance Division, which reviews, approves, and regulates Marketplace plans in Minnesota, to take immediate action against Medica for offering these substandard plans that violate the ACA and its implementing regulations.  We urge you to ensure that these violations are rectified before the new plan year begins. 

read more

Substandard & discriminatory HIV medication plan design and coverage by Medica in Iowa

These benefit designs, which discourage enrollment by Iowans living with HIV, are plainly discriminatory.  We urge the Iowa Insurance Division, which reviews, approves, and regulates Marketplace plans in Iowa, to take immediate action against Medica for offering these substandard plans that violate the ACA and its implementing regulations.  We urge you to ensure that these violations are rectified before the new plan year begins.

read more

Comments on the 2026 NBPP proposed rule

While we appreciate the many steps that you are taking to make healthcare more accessible and affordable for beneficiaries, the majority of this comment on the Proposed NBPP Rule focuses on the need for CMS and related federal agencies to take the necessary steps to increase access and affordability of prescription drugs that should have been included in the Draft NBPP Rule but were not.

read more

Pin It on Pinterest